Rozastin® 20 mg

The International Nonproprietory Name: Rosuvastatin
Indications for use:

The drug Rosostin is intended for:
Treatment of hypercholesterolemia ‒ primary hypercholesterolemia (type IIa, including familial heterozygous hypercholesterolemia) or mixed dyslipidemia (type IIb) as an adjunct to diet, when diet and other non-drug treatments (for example, exercise, weight loss) are insufficient in adults, adolescents and children over 6 years old.
Familial homozygous hypercholesterolemia in adults, adolescents and children over 6 years of age as an adjunct to diet and other lipid-lowering therapy (for example, LDL-apheresis), or in cases where such therapy is not effective enough.
Prevention of cardiovascular complications - prevention of major cardiovascular complications in patients who have a high risk of developing the first cardiovascular complication as a supplement to the correction of other risk factors.
  • Dosage and packaging
    20 mg №30
  • Scope of application
    Metabolic and energy disorders
  • Form of vacation
    On prescription
  • Pharmacotherapeutic group